Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 386 results for "Byetta"

California Federal Court Overseeing Byetta Lawsuits, Other Incretin...
PRWeb

California Federal Court Overseeing Byetta Lawsuits, Other Inc...

More than two dozen new claims were filed over the past month in a federal litigation involving Byetta lawsuits (http://www.byettalawsuit2013.com/), as well as cases over similar diabetes medications, Bernstein Liebhard LLP reports. A Case List ... Digital Journal, 8 hours ago
[x]  

1 images for "Byetta"

PRWeb, 8 hours ago

Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Reports

The Firm is evaluating Byetta lawsuits and other legal claims that allege the use of diabetes drugs called incretin mimetics caused patients to develop pancreatic cancer, pancreatitis or thyroid cancer. New York, New York (PRWEB) October 08, 2014 ...
 Benzinga.com1 month ago

AZs Byetta on par with Lillys Humalog in sugar control

Adding AstraZeneca's Byetta (exenatide) to basal insulin glargine/meformin is just as effective at lowering blood sugar in adults with type II diabetes as adding bolus insulin
 Big News Network1 month ago Diabetes drug exenatide as effective as bolus insulin in new study results  GM Journal1 month ago AstraZeneca's Byetta meets primary endpoint in diabetes trial and reduces weight  Pharma Letter1 month ago

Sanofi's New Medicines Seminar: Implications For Afrezza

Summary Sanofi's presentation to analysts today put the heaviest emphasis on several not-yet-approved drugs rather than Afrezza. They have good business reasons for doing this. Afrezza has a much easier path to success than the drugs that got the ...
 Seeking Alpha1 day ago

DexCom : Announces Appointment of Mark G. Foletta as Board Member

DexCom, Inc. (NASDAQ:DXCM) today announced the appointment of Mark G. Foletta as an independent Board member of the company. Mr. Foletta currently serves on the board of directors of AMN Healthcare Services and Regulus Therapeutics.
 4 Traders4 days ago DexCom Announces Appointment of Mark G. Foletta as Board Member  Nasdaq3 days ago
[x]  
PHP Developer's Journal

Legal-Bay Lawsuit Settlement Funding Reports Growing Number of Applications Based on Current Holiday Lawsuit Cash Advance Promotion

ORLANDO, Fla., Nov. 17, 2014 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that they are receiving an increased number of applications due to their current holiday promotion where they will be raffling off a ...
 Financial Content6 days ago
[x]  
MedIndia

Regular eye check-up can prevent Diabetic Retinopathy: ...

The epidemic called diabetes which has fast spread its tentacles across the globe can also lead to blindness if the patient is not careful and alert. With November being the diabetes awareness month, it is important that diabetics keep going for ...
 MedIndia6 days ago
Jutia Group

Market Update: Bristol-Myers Squibb Company (NYSE:BMY) Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban)

[GlobeNewswire] — Andexanet Alfa Rapidly Reversed the Anticoagulant Effect of the Factor Xa Inhibitor Eliquis (apixaban) Among All Study Participants Read more on this. Bristol-Myers Squibb Company (BMY) , currently valued at $96.39B, ...
 Jutia Group6 days ago Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) Multiple Bristol-Myers Squibb Oncology Compounds to be Featured in Oral Presentations at 56th Annual American Society for Hematology (ASH) Meeting  Jutia Group1 week ago Stock Update (NYSE:BMY): UPDATE 1-Bristol-Myers pulls U.S. marketing application for hepatitis C treatment  Jutia Group1 month ago Stock Update (NYSE:BMY): Bristol immunotherapy gets 6-month U.S. FDA review for melanoma  Jutia Group1 month ago

Use of selenium compounds, especially selenium yeasts for altering cognitive function

The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or ...
 PharmCast1 week ago Methods and compositions for altering cell function  PharmCast2 weeks ago

Will GLP market growth save Novo's Victoza from Lilly's new Trulicity?

When a new drug bursts upon an established drug class, the established players often wave away worries about market share. Sales for the whole class will grow, they say, because we'll have one more company on the street promoting it. Sometimes ...
 FiercePharma1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less